Market Pricing In Major Move for Frequency Therapeutics

There have been plenty of things happening in Frequency Therapeutics, Inc. (FREQ) of late. Recently, the share-price responded nicely to studies done in FX-322 (Hearing Loss). As we can see from the sky-high volatility in this stock at present, the market is pricing in a major move. We intend to take advantage of this fear by selling buckets of premium. Something like the sale of a strangle or an iron condor looks to be the strategy in here at present. With these levels of volatility, one should be able to put their short-strikes 20 to 40% away from the current share-price.

High Implied Volatility In FREQ

High Implied Volatility In FREQ

This entry was posted in Frequency Therapeutics and tagged . Bookmark the permalink.

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.